5160722025-10-012025-12-315160722025-12-315160722025-04-012025-12-315160722025-10-012025-12-31in-capmkt:OtherExpenses1Member5160722025-10-012025-12-31in-capmkt:OtherExpenses2Member5160722025-10-012025-12-31in-capmkt:OtherExpenses3Member5160722025-10-012025-12-31in-capmkt:OtherExpenses4Member5160722025-10-012025-12-31in-capmkt:OtherExpenses5Member5160722025-04-012025-12-31in-capmkt:OtherExpenses1Member5160722025-04-012025-12-31in-capmkt:OtherExpenses2Member5160722025-04-012025-12-31in-capmkt:OtherExpenses3Member5160722025-04-012025-12-31in-capmkt:OtherExpenses4Member5160722025-04-012025-12-31in-capmkt:OtherExpenses5Member5160722025-10-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15160722025-04-012025-12-31ItemsThatWillNotBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares516072VISHNUNOTLISTEDINE270I01022VISHNU CHEMICALS LIMITEDMain BoardEquity2025-04-012026-03-312026-01-312026-01-23INRLakhsQuarterlyThird quarterSingle segmentOperating Segment2026-01-3115:00:002026-01-3115:40:00Not applicablefalsetrue2025-10-012025-12-31UnauditedStandalone305145900064212000311567100015599110000-6558500014773400059381000616510001061831000282492300029074800002907480006503200067330007176500002189830000000218983000-52300021846000013463100023.253.25003.253.25Notes : <BR> 1 The above unaudited Standalone Financial Results of Vishnu Chemicals Limited ("the Company'') as reviewed by the audit committee has been approved by the Board of Directors at its meeting held on January 31, 2026. The Statutory Auditors of the company have carried out a limited review on the standalone financial results for the quarter ended December 31, 2025 and expressed an unmodified opinion thereon. <BR> <BR> 2 The standalone financial results of the Company have been prepared in accordance with the Indian Accounting Standards ('IND AS') prescribed under Section 133 of the Companies Act, 2013 ("the Act") read with relevant rules issued thereunder and other accounting principles generally accepted in India and guidelines issued by the Securities and Exchange Board of India ("SEBI") <BR> <BR> 3. Previous year's figures have been regrouped/reclassified/rearranged wherever necessary to correspond with those of the current year. <BR> <BR> 4. The Company is engaged in the manufacture and sale of Specialty Chemicals, which constitutes a single reportable business segment as per Ind AS 108 - "Operating Segments". However, the company has two geographical revenue areas i.e. (1) Domestic (2) Overseas. The breakup of Income is as under: <BR> <BR> Rs. in lakhs <BR> <BR> Sl. <BR> No. Particulars Quarter Ended Nine Months ended Year Ended <BR> 31-Dec-2025 30-Sep-2025 31-Dec-2024 31-Dec-2025 31-Dec-2024 31-Mar-2025 <BR> ( Unaudited ) ( Unaudited ) ( Unaudited ) ( Unaudited ) ( Unaudited ) ( Audited ) <BR> 1 Domestic 14,055.89 15,685.93 13,661.84 43,763.42 42,206.93 60,188.85 <BR> 2 Overseas 16,386.55 14,662.00 14,250.09 43,175.28 37,810.64 48,846.27 <BR> Total Sales 30,442.44 30,347.93 27,911.93 86,938.70 80,017.57 1,09,035.12 <BR> <BR> 2025-04-012025-12-31UnauditedStandalone8724842000202086000892692800046271090000-3540160004067950001838880001815090003087285000813257000079435800007943580001823260001768600020001200005943460000000594346000-112200059322400013463100028.838.83008.838.83Cost of Consumables375091000Power Cost169724000Manufacturing expenses214928000Selling & Administrative expenses295457000Other Expenses6631000Cost of Consumables1093453000Power Cost492806000Manufacturing expenses574096000Selling & Administrative expenses907037000Other Expenses19893000Remeasurement gains/(loss) on defined benefit Plans-700000-700000Remeasurement gains/(loss) on defined benefit Plans-1500000-1500000-177000-37800000-523000-112200014117000000002037300000